360 related articles for article (PubMed ID: 27978865)
1. [Synergistic Antitumor Effect of Amorphigenin Combined with Cisplatin in Human Lung Adenocarcinoma A549/DDP Cells].
Zhong H; Zuo Y; Wu X; Peng Y; He H; Yang J; Guan C; Xu Z
Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):805-812. PubMed ID: 27978865
[TBL] [Abstract][Full Text] [Related]
2. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
Gong X; Liu J; Zhang D; Yang D; Min Z; Wen X; Wang G; Li H; Song Y; Bai C; Li J; Zhou J
PLoS One; 2017; 12(8):e0182410. PubMed ID: 28771580
[TBL] [Abstract][Full Text] [Related]
3. [The roles of holothurian glycosaminoglycan combined with cisplatin on proliferation and chemotherapeutic response in A549 human lung adenocarcinoma cell].
Jin Q; Zhu XH; Lin CZ; Zhang H; Cao YW; Ding XQ; Lyu ZH
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):252-257. PubMed ID: 29730910
[No Abstract] [Full Text] [Related]
4. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
[TBL] [Abstract][Full Text] [Related]
5. Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms.
Ye MX; Zhao YL; Li Y; Miao Q; Li ZK; Ren XL; Song LQ; Yin H; Zhang J
Phytomedicine; 2012 Jun; 19(8-9):779-87. PubMed ID: 22483553
[TBL] [Abstract][Full Text] [Related]
6. The effects of combined treatment with sevoflurane and cisplatin on growth and invasion of human adenocarcinoma cell line A549.
Liang H; Wang HB; Liu HZ; Wen XJ; Zhou QL; Yang CX
Biomed Pharmacother; 2013 Jul; 67(6):503-9. PubMed ID: 23639227
[TBL] [Abstract][Full Text] [Related]
7. Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP.
Wei Y; Wu S; Xu W; Liang Y; Li Y; Zhao W; Wu J
Thorac Cancer; 2017 Jan; 8(1):26-32. PubMed ID: 27813328
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of sorafenib on the A549/DDP human lung adenocarcinoma cell line in vitro.
Chen XQ; Wang YL; Li ZY; Lin TY
Mol Med Rep; 2014 Jul; 10(1):347-52. PubMed ID: 24788469
[TBL] [Abstract][Full Text] [Related]
9. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
[TBL] [Abstract][Full Text] [Related]
10. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
[TBL] [Abstract][Full Text] [Related]
11. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
[TBL] [Abstract][Full Text] [Related]
12. Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc.
Zuo Y; Yang D; Yu Y; Xiang M; Li H; Yang J; Li J; Jiang D; Zhou H; Xu Z; Yu Z
Mol Med Rep; 2018 Mar; 17(3):3497-3502. PubMed ID: 29257330
[TBL] [Abstract][Full Text] [Related]
13. Reversal of galectin-1 gene silencing on resistance to cisplatin in human lung adenocarcinoma A549 cells.
Zhang L; Liu X; Tang Z; Li X; Wang G
Biomed Pharmacother; 2016 Oct; 83():265-270. PubMed ID: 27392028
[TBL] [Abstract][Full Text] [Related]
14. Id4 promotes cisplatin resistance in lung cancer through the p38 MAPK pathway.
Qi K; Li Y; Li X; Lei X; Wang B; Zhang L; Chu X
Anticancer Drugs; 2016 Nov; 27(10):970-8. PubMed ID: 27537399
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
[TBL] [Abstract][Full Text] [Related]
16. [Increased expression of acetaldehyde dehydrogenase in cisplatin-resistant human lung adenocarcinoma A549/DDP cells].
He J; Song X; Yu L; Li J; Qiao Z; Jiu R; Yu B; Liu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):625-9. PubMed ID: 25940289
[TBL] [Abstract][Full Text] [Related]
17. C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
Xie C; Pan Y; Hao F; Gao Y; Liu Z; Zhang X; Xie L; Jiang G; Li Q; Wang E
APMIS; 2014 Dec; 122(12):1251-8. PubMed ID: 25131138
[TBL] [Abstract][Full Text] [Related]
18. The role of emodin on cisplatin resistance reversal of lung adenocarcinoma A549/DDP cell.
Teng X; Wang SY; Shi YQ; Fan XF; Liu S; Xing Y; Guo YY; Dong M
Anticancer Drugs; 2021 Oct; 32(9):939-949. PubMed ID: 34001704
[TBL] [Abstract][Full Text] [Related]
19. Baicalin attenuates DDP (cisplatin) resistance in lung cancer by downregulating MARK2 and p-Akt.
Xu Z; Mei J; Tan Y
Int J Oncol; 2017 Jan; 50(1):93-100. PubMed ID: 27878245
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of ATP-binding cassette B1 (ABCB1) multidrug resistance 1 (MDR1) is associated with cisplatin resistance in the A549 lung adenocarcinoma cell line.
Li A; Song J; Lai Q; Liu B; Wang H; Xu Y; Feng X; Sun X; Du Z
Int J Exp Pathol; 2016 Dec; 97(6):412-421. PubMed ID: 27995666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]